This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
Shanghai, China
Save the date for next yearApril 2026

Gabriele Grecchi
CEO at CaSRevolution
Presenter

Profile

CaSRevolution is an Italian-based biotech developing innovative Alzheimer’s therapies by targeting the Calcium Sensing Receptor (CaSR) in astrocytes and neurons. Using Negative Allosteric Modulators, our approach blocks Abeta-triggered neurotoxicity, halting the cascade that leads to amyloid plaques, tau hyperphosphorylation, and neuroinflammation. Backed by robust preclinical data, we are advancing a novel, mechanism-based treatment to meet the unmet needs of AD patients

Agenda Sessions

  • Startup Spotlight Pitch Competition Sponsored by Pfizer

    09:05